Search research articles
Contact Us
Filters
Showing results (11-20 of 49) with videos related to
Page
of 5
Sort By:
BMJ Case Reports
|
October 23, 2012
Vasculitides associated with haematological malignancies: a case-based review
Shuchi Gulati, Nirav P Patel, Sharon L Swierczynski
North American Journal of Medical Sciences
|
March 25, 2016
Ocular Adnexal Lymphoma Presenting with Visual Loss
Shuchi Gulati, Zélia M Corrêa, Nagla Karim, et al.
Cancer Treatment and Research Communications
|
April 7, 2020
Evolving treatment paradigm in metastatic non clear cell renal cell carcinoma
Shuchi Gulati, Errol Philip, Sabrina Salgia, et al.
Journal of Community Hospital Internal Medicine Perspectives
|
October 16, 2014
Surprising cause of dysphagia in an elderly male
Kyle Bennett, Suzanne Supplee, Priyanka Vyas, et al.
Urologic Oncology
|
January 16, 2021
Systemic therapy and COVID19: Immunotherapy and chemotherapy
Shuchi Gulati, Ramya Muddasani, Paulo Gustavo Bergerot, et al.
The Oncologist
|
May 31, 2022
First-Line Treatments for Metastatic Clear Cell Renal Cell Carcinoma: An Ever-Enlarging Landscape
Shuchi Gulati, Chris Labaki, Georgia Sofia Karachaliou, et al.
Journal of Gastrointestinal Oncology
|
January 13, 2017
Advanced biliary tract cancer: clinical outcomes with ABC-02 regimen and analysis of prognostic factors in a tertiary care center in the United States
Rishi Agarwal, Arun Sendilnathan, Nabeela Iffat Siddiqi, et al.
Clinical Genitourinary Cancer
|
December 13, 2023
Therapy With Metronomic Cyclophosphamide (mCyc) for Previously-Treated Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
Nataliya Mar, Sami Dwabe, Marlon N Baranda, et al.
Genes
|
April 3, 2021
Molecular and Metabolic Subtypes in Sporadic and Inherited Clear Cell Renal Cell Carcinoma
Maria F Czyzyk-Krzeska, Julio A Landero Figueroa, Shuchi Gulati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2023
Durvalumab plus Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: An Open-label, Nonrandomized, Phase II Clinical Trial
Shuchi Gulati, McKenzie Crist, Muhammed Kashif Riaz, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 49) with videos related to
Sort By:
Page
of 5
BMJ Case Reports
|
October 23, 2012
Vasculitides associated with haematological malignancies: a case-based review
Shuchi Gulati, Nirav P Patel, Sharon L Swierczynski
North American Journal of Medical Sciences
|
March 25, 2016
Ocular Adnexal Lymphoma Presenting with Visual Loss
Shuchi Gulati, Zélia M Corrêa, Nagla Karim, et al.
Cancer Treatment and Research Communications
|
April 7, 2020
Evolving treatment paradigm in metastatic non clear cell renal cell carcinoma
Shuchi Gulati, Errol Philip, Sabrina Salgia, et al.
Journal of Community Hospital Internal Medicine Perspectives
|
October 16, 2014
Surprising cause of dysphagia in an elderly male
Kyle Bennett, Suzanne Supplee, Priyanka Vyas, et al.
Urologic Oncology
|
January 16, 2021
Systemic therapy and COVID19: Immunotherapy and chemotherapy
Shuchi Gulati, Ramya Muddasani, Paulo Gustavo Bergerot, et al.
The Oncologist
|
May 31, 2022
First-Line Treatments for Metastatic Clear Cell Renal Cell Carcinoma: An Ever-Enlarging Landscape
Shuchi Gulati, Chris Labaki, Georgia Sofia Karachaliou, et al.
Journal of Gastrointestinal Oncology
|
January 13, 2017
Advanced biliary tract cancer: clinical outcomes with ABC-02 regimen and analysis of prognostic factors in a tertiary care center in the United States
Rishi Agarwal, Arun Sendilnathan, Nabeela Iffat Siddiqi, et al.
Clinical Genitourinary Cancer
|
December 13, 2023
Therapy With Metronomic Cyclophosphamide (mCyc) for Previously-Treated Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
Nataliya Mar, Sami Dwabe, Marlon N Baranda, et al.
Genes
|
April 3, 2021
Molecular and Metabolic Subtypes in Sporadic and Inherited Clear Cell Renal Cell Carcinoma
Maria F Czyzyk-Krzeska, Julio A Landero Figueroa, Shuchi Gulati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2023
Durvalumab plus Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: An Open-label, Nonrandomized, Phase II Clinical Trial
Shuchi Gulati, McKenzie Crist, Muhammed Kashif Riaz, et al.
Page
of 5